AdvaMed CEO Talks Azar, Device Tax, Legislative Strategy

Citeline Podcasts - A podcast by Citeline

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

In a Medtech Insight exclusive, AdvaMed CEO Scott Whitaker talked about advising Trump HHS nominee Alex Azar on his confirmation process, frustration with permanently repealing the medical device tax, potential for another temporary tax moratorium and lobbying priorities for 2018.

Visit the podcast's native language site